Linear Clinical Research Ltd
Simon Martin is a seasoned financial executive with extensive experience in leadership roles across various sectors. Currently serving as the Chief Financial Officer at Linear Clinical Research since July 2025, Simon previously held the same title at WA Primary Health Alliance from September 2015 to June 2025. Notably, Simon acted as the Interim CEO of Cystic Fibrosis Australia from November 2014 to August 2015, advocating for the cystic fibrosis community. Earlier in Simon's career, positions included General Manager and Finance Manager at Network Ten, Finance Executive at Texaco Ltd in London, and Senior Consultant at EY. Educational qualifications include a Graduate degree from the Australian Institute of Company Directors and a Chartered Accountant designation from Chartered Accountants Australia and New Zealand, complemented by a Bachelor of Commerce from The University of Western Australia.
This person is not in any teams
This person is not in any offices
Linear Clinical Research Ltd
As a world class leader, Linear Clinical Research (Linear) is a purpose built state-of-the-art, clinical trials facility operating out of QEII Medical Centre in Perth, Western Australia. Conceived as a focal point for Australian clinical and medical research, Linear is making innovative therapies available to our local community. At Linear the focus is on its phase I facility to support first in human through to phase II clinical trials, including oncology studies. Linear have extensive experience in conducting both healthy volunteer and patient phase I trials, including adaptive healthy volunteer and patient protocol designs. Linear has a variety of departments that specialise in running the clinical trial from business development, start up, recruitment and screening, project teams, quality assurance and laboratory. Each department works together to ensure clinical trials are run safely and efficiently. Reliable clinical trial data is one thing, but at Linear we go further. We actively listen, contribute ideas and add value at every stage of your medical mission, so you can realise your therapy’s medical and commercial potential sooner. Located in Australia, where Australia offers a fast regulatory framework to move into human trials without requiring an investigational new drug, Linear is constantly developing capabilities and services to meet the ever-changing demands of our customers. Our vision is to be the first choice for patient empowered trials globally and recognised for innovation and excellence. Our “One Linear” values are: - Excellence - Respect - Integrity - Collaboration